AU Patent

AU2000275584A1 — Anticancer compositions

Assigned to Orient Cancer Therapy Co Ltd · Expires 2001-08-07 · 25y expired

What this patent protects

Patent listed against Subutex.

Drugs covered by this patent

Subutex (BUPRENORPHINE) · Purdue Pharma Lp

Patent Metadata

Patent number: AU2000275584A1
Jurisdiction: AU
Classification: —
Expires: 2001-08-07
Drug substance claim: No
Drug product claim: No
Assignee: Orient Cancer Therapy Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.